Ultragenyx Pharmaceutical Inc. SEC filings RARE
Ultragenyx Pharmaceutical Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jul 20, 2015. Its latest annual report, Form ARS, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (acquisition or sale of assets, results of operations, exit or restructuring costs). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Jun 10, 2024 | — |
| CORRESP | Letter to the SEC | May 17, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2024 | — |
| SEC STAFF LETTER | Filing | Dec 2, 2019 | — |
| SEC STAFF LETTER | Filing | Nov 6, 2019 | — |
| CT ORDER | Filing | Aug 30, 2018 | — |
| CT ORDER | Filing | Apr 20, 2018 | — |
| SC TO-T/A | Filing | Nov 7, 2017 | — |
| SC TO-T/A | Filing | Oct 26, 2017 | — |
| SC TO-T/A | Filing | Oct 23, 2017 | — |
| SC TO-T/A | Filing | Oct 17, 2017 | — |
| SC TO-T/A | Filing | Oct 12, 2017 | — |
| SC TO-T/A | Filing | Oct 11, 2017 | — |
| SC TO-T | Filing | Oct 10, 2017 | — |
| SC TO-C | 8-k | Oct 3, 2017 | — |
| SC TO-C | Form 8-k | Oct 2, 2017 | — |
| SC TO-C | Form 8-k | Sep 25, 2017 | — |
| SC TO-C | 8-k | Sep 19, 2017 | — |
| SC TO-C | Form 8-k | Sep 18, 2017 | — |
| CT ORDER | Filing | Jan 13, 2017 | — |
| CT ORDER | Filing | Jan 9, 2017 | — |
| CT ORDER | Filing | Dec 22, 2015 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RARE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Novato, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1515673
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.